Query 1: "Stock Private Label vs. Custom Formula Manufacturing — Which Yields Higher ROI?"
Global buyers often query whether to launch using ready-to-brand stock formulas or invest in custom R&D formulations. Stock private label nutraceuticals reduce time-to-market from 6 months down to 4–6 weeks, minimizing capital expenditure with lower minimum order quantities (from 5,000 units). Conversely, custom formulation allows brands to patent proprietary active ratios, utilize trademarked branded ingredients (e.g., KSM-66®, Cognizin®), and engineer specific organoleptic characteristics. Enova Science bridges this gap by offering fast-turn stock formulas alongside full-scale custom pilot trials produced in 5 business days.







